Interferon and Interferon Inducers: Clinical Application [PDF]
openaire +1 more source
Upon inhalation, RM@TNT could persist long‐term in the diseased lungs, while undergoing disintegration to release TNT specifically within the ROS‐rich pathological microenvironments of SA‐ARDS. The released TNT was then precisely delivered to AMs via Tuftsin, where it released Nob intracellularly to activate BMAL1 expression, thus inhibiting AM ...
Yunlong Zhang +23 more
wiley +1 more source
Ferroptosis and metabolic reprogramming in the immunosuppressive microenvironment of glioblastoma: emerging mechanisms and novel strategies. [PDF]
Han L, Wang Z, Jiang Y, Zhou H, Zhou H.
europepmc +1 more source
A fluorescent lectin-agarose bead immunoassay for pancreatic autoantigen involved in Crohn´s disease [PDF]
Horbach, E. +5 more
core
This research identifies DTX3L as a critical tumor suppressor that inhibits epithelial‐mesenchymal transition (EMT), invasion and metastasis in gastric cancer. By functioning as an E3 ubiquitin ligase, DTX3L targets the master EMT regulator SNAI1 for GSK‐3β‐dependent proteasomal degradation.
Yang Chen +7 more
wiley +1 more source
Interferon signaling and STING pathway in head and neck cancers: unlocking immune secrets and therapeutic frontiers. [PDF]
Zolfaghari K +6 more
europepmc +1 more source
Gesteigerte Immunogenität von Plasmamembranen vacciniavirus-infizierter BHK-Zellen [PDF]
Bandlow, G. +2 more
core
This review explores how hemoglobin‐based oxygen carriers (HBOCs) combined with nanozymes create multifunctional materials that deliver oxygen while maintaining redox homeostasis. Beyond artificial blood substitutes, these constructs enable wound healing with light‐triggered oxygen release, cancer therapy through enhanced oxygenation and reactive ...
Despoina Douka +4 more
wiley +1 more source
Recent perspectives on macrophage memory: types, mechanisms, and characteristics in pulmonary diseases. [PDF]
Wang S +6 more
europepmc +1 more source
Blocking of the B7-CD28 pathway increases the capacity of FasL+ (CD95L+) dendritic cells to kill alloactivated T cells [PDF]
AW Thomson +22 more
core +1 more source

